EDTA | Jotup

EDTA Board of Directors Announces New Leadership and Welcomes Walmart as a Member

Retrieved on:

Wednesday, March 13, 2024

EV, World Electric Vehicle Association, Government, Chair, Pepco Holdings, Strategic planning, CenterPoint Energy, Transport, Ford Motor Company, Walmart, Senior, EDTA, Inflation, Human, Management

Washington, DC, March 13, 2024 (GLOBE NEWSWIRE) -- The Electric Drive Transportation Association (EDTA) elected a new Chair and Treasurer at its quarterly Board of Directors meeting in Washington, DC.

Key Points:

Washington, DC, March 13, 2024 (GLOBE NEWSWIRE) -- The Electric Drive Transportation Association (EDTA) elected a new Chair and Treasurer at its quarterly Board of Directors meeting in Washington, DC.
Andre Welch, Director of Government Relations at Ford Motor Company, was elected Chair.
Christopher Hess, Vice President of Global Public Affairs at Eaton, was elected Treasurer.
The EDTA Board acknowledged their outstanding leadership and service to the association and its mission of advancing electric drive technologies and their benefits, including recent efforts to guide the implementation of the Inflation Reduction Act and the Bipartisan Infrastructure Law.

Antech launches breakthrough in-hospital innovation, Nu.Q® Canine Cancer Test

Retrieved on:

Friday, January 12, 2024

Element, Hemangiosarcoma, VMX, Volition, EDTA, Dog, Science, Pet, Cancer, Lymphoma, Plasma, Disease, DVM, Transport, Nucleosome, Telehealth, Veterinarian

ORLANDO, Fla., Jan. 12, 2024 /PRNewswire/ -- Antech, the veterinary diagnostics company focused on helping veterinary professionals predict, diagnose and monitor wellness and disease, today announced it will launch the breakthrough in-hospital Nu.Q® Canine Cancer Test at this year's annual VMX meeting.

Key Points:

ORLANDO, Fla., Jan. 12, 2024 /PRNewswire/ -- Antech, the veterinary diagnostics company focused on helping veterinary professionals predict, diagnose and monitor wellness and disease, today announced it will launch the breakthrough in-hospital Nu.Q® Canine Cancer Test at this year's annual VMX meeting.
Nu.Q ® is a breakthrough technology that measures circulating nucleosomes, supporting earlier cancer detection in some of the most prevalent types of canine cancers.
To learn more about the in-hospital Nu.Q ®, visit booth 1522 at VMX 2024 or speak to your local Antech representative.
The Nu.Q® Canine Cancer Test is supplied to Antech's Heska affiliate under license by Belgian Volition SRL.

Immunexpress Announces U.S. FDA Clearance of EDTA Blood Compatible Cartridges for SeptiCyte RAPID®

Retrieved on:

Thursday, January 4, 2024

RNA, HHS, Food, Ellery Sedgwick, Collection, Heart, Drive, Research, FDA, Sepsis, Lung, Assistant, Patient, Diagnosis, Development, EDTA, Medical device

SEATTLE and BRISBANE, Australia, Jan. 4, 2024 /PRNewswire/ -- Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, announced today the clearance of EDTA blood compatible cartridges by the U.S. Food and Drug Administration (FDA) for use with SeptiCyte RAPID®. The updated SeptiCyte® RAPID cartridges add undiluted EDTA blood as a validated sample type within the U.S. healthcare market and have been available on the European market since August 2022.

Key Points:

SEATTLE and BRISBANE, Australia, Jan. 4, 2024 /PRNewswire/ -- Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, announced today the clearance of EDTA blood compatible cartridges by the U.S. Food and Drug Administration (FDA) for use with SeptiCyte RAPID®.
The updated SeptiCyte® RAPID cartridges add undiluted EDTA blood as a validated sample type within the U.S. healthcare market and have been available on the European market since August 2022.
Their implementation allows for the use of standard EDTA blood collection tubes in place of proprietary PAXgene® blood RNA tubes.
BARDA awarded this grant to Immunexpress in 2020 as part of the DRIVe Solving Sepsis program.

Arqit Quantum Inc. Announces Financial and Operational Results for the Fiscal Year 2023

Retrieved on:

Tuesday, November 21, 2023

LONDON, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) (“Arqit”), a global leader in quantum-safe encryption, today announced its operational and financial results for the full fiscal year 30 September 2023.

Key Points:

Arqit WalletSecure™ will be offered as part of an existing product offering of a major global financial services company.
During the second half of fiscal year 2023, Arqit delivered on revenue contracts with six channel partners representing sales of QuantumCloud™ Private Instance, QuantumCloud™ PaaS, Arqit NetworkSecure™ and Arqit TradeSecure™.
For the fiscal year ending 30 September 2023, Arqit issued 7,814,459 shares under the ATM Program, generating gross proceeds of $11.5 million.
Following the cost reduction initiative implemented in May 2023, Arqit’s headcount was 147 as of fiscal year end 2023.

Agricultural Micronutrients Market worth $6.9 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on:

Wednesday, November 8, 2023

Fertilizer, Temperature, Health, Food, Government, Humidity, Boron, Region, Prevalence, Iron, Micronutrient, Growth, Boron deficiency, Grain, Farmer, Soil, Food security, USD, EDTA, Dry, DTPA, EDDHA, Vegetable, Appetite, Fertigation

Boron, as an essential micronutrient in the agricultural micronutrients market, is experiencing rapid growth due to various influential factors.

Key Points:

Boron, as an essential micronutrient in the agricultural micronutrients market, is experiencing rapid growth due to various influential factors.
By mode of application, the fertigation segment is anticipated to grow at a significant rate in the agricultural micronutrients market.
Fertigation, the practice of applying micronutrients through irrigation systems, is gaining momentum in the agricultural micronutrients market due to several factors fastening its growth.
The cereal and grain crop type is anticipated to grow at a significant CAGR in the global agricultural micronutrients market.

Agricultural Micronutrients Market worth $6.9 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on:

Wednesday, November 8, 2023

Boron, as an essential micronutrient in the agricultural micronutrients market, is experiencing rapid growth due to various influential factors.

Key Points:

Boron, as an essential micronutrient in the agricultural micronutrients market, is experiencing rapid growth due to various influential factors.
By mode of application, the fertigation segment is anticipated to grow at a significant rate in the agricultural micronutrients market.
Fertigation, the practice of applying micronutrients through irrigation systems, is gaining momentum in the agricultural micronutrients market due to several factors fastening its growth.
The cereal and grain crop type is anticipated to grow at a significant CAGR in the global agricultural micronutrients market.

Secro, the new-generation e-bill of lading, achieves further legal and technical reliability certification

Retrieved on:

Friday, November 3, 2023

Singapore, ETDA, EDTA, HFW, Silicon, Electronic trading platform

Today, companies and banks willing to expedite and de-risk their transactions with e-bills of lading can do it with stronger certainty of legal recognition in front of courts and arbitrators.

Key Points:

Today, companies and banks willing to expedite and de-risk their transactions with e-bills of lading can do it with stronger certainty of legal recognition in front of courts and arbitrators.
The first is its legal validity under both the Singapore Electronic Transaction Act and the more recent English ETDA, which translates into high flexibility.
The second is its technical and legal reliability even without the use of cumbersome, multiparty agreements.
To learn more about Secro please visit our website https://secro.io or contact [email protected] for a free trial of our platform.

Invizius Announces Appointment of World-Renowned Nephrologist Professor Bernard Canaud to its Clinical Advisory Board

Retrieved on:

Tuesday, October 24, 2023

GLASGOW, Scotland, Oct. 24, 2023 /PRNewswire/ -- Invizius Limited ("Invizius"), a biotechnology company developing breakthrough treatments for patients on dialysis, is pleased to announce the appointment of Professor Bernard Canaud to its Clinical Advisory Board.

Key Points:

GLASGOW, Scotland, Oct. 24, 2023 /PRNewswire/ -- Invizius Limited ("Invizius"), a biotechnology company developing breakthrough treatments for patients on dialysis, is pleased to announce the appointment of Professor Bernard Canaud to its Clinical Advisory Board.
Professor Canaud is a leading authority on kidney disease and dialysis.
Richard Boyd, Chief Executive Officer of Invizius, said: "We are delighted and honored to have Professor Canaud join Invizius at an important time of growth and development for the company.
Professor Bernard Canaud, commented: "Invizius' unique product H-Guard has the potential to reduce the therapeutic burden and save patients' lives by addressing the inappropriate activation of the complement system.

Invizius Announces Appointment of World-Renowned Nephrologist Professor Bernard Canaud to its Clinical Advisory Board

Retrieved on:

Tuesday, October 24, 2023

GLASGOW, Scotland, Oct. 24, 2023 /PRNewswire/ -- Invizius Limited ("Invizius"), a biotechnology company developing breakthrough treatments for patients on dialysis, is pleased to announce the appointment of Professor Bernard Canaud to its Clinical Advisory Board.

Key Points:

GLASGOW, Scotland, Oct. 24, 2023 /PRNewswire/ -- Invizius Limited ("Invizius"), a biotechnology company developing breakthrough treatments for patients on dialysis, is pleased to announce the appointment of Professor Bernard Canaud to its Clinical Advisory Board.
Professor Canaud is a leading authority on kidney disease and dialysis.
Richard Boyd, Chief Executive Officer of Invizius, said: "We are delighted and honored to have Professor Canaud join Invizius at an important time of growth and development for the company.
Professor Bernard Canaud, commented: "Invizius' unique product H-Guard has the potential to reduce the therapeutic burden and save patients' lives by addressing the inappropriate activation of the complement system.

An Optimized AAV Sample Preparation Method for Robust Quantification of Viral Titers by PCR, Upcoming Webinar Hosted by Xtalks

Retrieved on:

Wednesday, October 11, 2023

Workflow, DNA, Polymerase chain reaction, AAV, Vivisection, Research, Nested polymerase chain reaction, DNASE1L1, EDTA, Genome, Laboratory, PCR, Vaccine

TORONTO, Oct. 11, 2023 /PRNewswire-PRWeb/ -- Discover a groundbreaking webinar delving into an optimal DNase-I application for digital polymerase chain reaction (dPCR) treatment for Adeno-associated virus (AAV) workflows. For AAV applications ranging from research tools to clinical-stage gene therapeutic strategies, the ability to quantify AAV vector concentration precisely and reproducibly is crucial. While several analytical methods are available, dPCR is one of the most robust and reliable ways to determine the absolute quantification of viral DNA at various stages of production.

Key Points:

The featured speaker will discuss an optimized approach for PCR sample preparation that can be utilized at any stage of the AAV workflow (from harvest to polishing).
TORONTO, Oct. 11, 2023 /PRNewswire-PRWeb/ -- Discover a groundbreaking webinar delving into an optimal DNase-I application for digital polymerase chain reaction (dPCR) treatment for Adeno-associated virus (AAV) workflows.
For AAV applications ranging from research tools to clinical-stage gene therapeutic strategies, the ability to quantify AAV vector concentration precisely and reproducibly is crucial.
Join Zoe Bowman, Research Associate, Teknova , for the live webinar on Wednesday, October 25, 2023, at 10am PDT (1pm EDT).